CHIKUN/KAJURU REP, HON. FIDELIX BAGUDU, ANNOUNCES NEW APPOINTMENTS TO STRENGTHEN INCLUSIVE GOVERNANCE. (PHOTO).

Image
  Chikun/Kajuru Rep, Hon. Fidelix Bagudu, Announces New Appointments To Strengthen Inclusive Governance The Honourable Member representing the Chikun/Kajuru Federal Constituency, Hon. Fidelix Joseph Bagudu, has announced a wide-ranging list of new appointments aimed at deepening inclusive governance and enhancing representation across the constituency. The appointments, which take immediate effect, were unveiled in alignment with Kaduna State Governor Senator Uba Sani’s commitment to participatory governance. According to the lawmaker’s office, the list reflects deliberate efforts to ensure fair representation of all wards, communities, and interest groups across Chikun and Kajuru Local Government Areas (LGAs). A statement issued by the Media and Publicity Directorate noted that the move also fulfills the Honourable Member’s campaign pledge to integrate every segment of the constituency into the decision-making and governance structure. The appointments cover several categories, in...

DEXAMETHASONE IS THE CURE TO COVID-19 AS 'WHO' WELCOMES PRELIMINARY RESULTS ABOUT THE USE OF THE DRUG IN TREATING CRITICALLY ILL COVID-19 PATIENTS.{PHOTOS}.#PRESS RELEASE.

What is Dexamethasone? | What Is News,The Indian Express
     The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.
The benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease. 
“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”
Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.


The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.One more photo below.
What is Dexamethasone, does it treat coronavirus and what is it ...

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.